Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > EY sees bolt-ons in the single to double digit billions now

<< Previous

Bullboard Posts

Next >>

Comment by jimsenioron Oct 13, 2022 6:53pm

190 Views

Post# 35023706

RE:RE:RE:RE:RE:RE:RE:EY sees bolt-ons in the single to double digit billions now

Yes. Well said. I stumbled across the following this afternoon, and whilst not necessarily related to pela it is the best 2 hours I have ever spent, and will interest my fellow shareholders who are interested in science. I was going to post it alone but it seems to fit with your post.

Search: Mind-Blowing Facts About Our Reality The Secrets of Quantum Physics.

It would be presumptuous in the extreme for me to say any more at this moment.

CHEERS

<< Previous

Bullboard Posts

Next >>

Yukon agency detects cyanide near Victoria Gold's Eagle mine